Skip to main navigation

Press Releases

Year

Mar 27, 2026

Autolus Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates

Mar 16, 2026

Autolus Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on March 27, 2026

Feb 24, 2026

Autolus Therapeutics to Participate in Upcoming Investor Conferences

Feb 04, 2026

Autolus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Jan 12, 2026

Autolus Therapeutics Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Net Product Revenue, Pipeline Advancements and Outlook for 2026

Jan 06, 2026

Autolus Therapeutics to Evaluate Automated Manufacturing of AUCATZYL® (obe-cel) on the Cellares Cell Shuttle™ Platform